V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Portfolio 13F
Dodge & Cox Stock Fund Holdings Activity
- Portfolio value:
- $113.76B≈ (+$2B≈)
- Previous value:
- $111.59B≈
- # of changes:
- 61
- New positions:
- 1
- Reported for:
- 31 Mar 2025 (Q1)
- Latest filing date:
- 27 May 2025
Dodge & Cox Stock Fund has disclosed a total of 61 changes to the portfolio in the (2025 Q1) SEC report(s): increased the number of shares of 20, bought 1 totally new, decreased the number of shares of 38 and completely sold out 2 position(s).
What stocks did Dodge & Cox Stock Fund buy in 2025 Q1?
During 2025 Q1 Dodge & Cox Stock Fund has bought 21 securities out of which top 5 purchases (by % change to portfolio) were (CVS) CVS Health Corp (added shares +4.73%), (OXY) Occidental Petroleum Corp (added shares +14.49%), (CMCSA) Comcast Corp (added shares +20.47%), (GSK) GlaxoSmithKline PLC ADR (added shares +16.83%) and (BUD) Anheuser Busch Inbev NV ADR (added shares +3.87%).
61 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TAIWAN SEMICONDUCTOR MANUFAC
|
new
|
+10,361,600
|
10,361,600
|
+0.25%
|
$27.88
|
-38.16%($17.24)
|
0.25%
|
2025 Q1
|
≈ 0.25 years
|
|
|
|
Fortive Corp
|
+209.43%
|
+9,919,688
|
14,656,300
|
+0.64%
|
$73.18
|
-19.09%($59.21)
|
0.94%
|
2024 Q4
|
≈ 0.50 years
|
|
|
|
Neurocrine Biosciences Inc
|
+101.28%
|
+1,994,564
|
3,964,000
|
+0.19%
|
$110.60
|
+50.60%($166.56)
|
0.39%
|
2023 Q3
|
≈ 1.75 years
|
|
|
|
LPL Financial Holdings Inc
|
+54.16%
|
+118,523
|
337,353
|
+0.03%
|
$327.14
|
+7.35%($351.18)
|
0.10%
|
2024 Q4
|
≈ 0.50 years
|
|
|
|
ASHTEAD GROUP PLC
|
+51.83%
|
+8,143,446
|
23,855,300
|
+0.39%
|
$54.00
|
|
1.13%
|
2024 Q2
|
≈ 1.00 year
|
|
|
|
Sun Communities Inc
|
+46.14%
|
+3,234,700
|
10,244,600
|
+0.37%
|
$128.64
|
-4.00%($123.50)
|
1.16%
|
2024 Q1
|
≈ 1.25 years
|
|
|
|
Air Products and Chemicals Inc
|
+33.93%
|
+1,475,100
|
5,821,951
|
+0.38%
|
$294.92
|
-0.40%($293.74)
|
1.51%
|
2024 Q3
|
≈ 0.75 years
|
|
|
|
Comcast Corp
|
+20.47%
|
+10,438,100
|
61,430,094
|
+0.34%
|
$36.90
|
-35.03%($23.98)
|
1.99%
|
2019 Q3
|
≈ 5.75 years
|
|
|
|
News Corp A
|
+17.76%
|
+1,589,500
|
10,541,090
|
+0.04%
|
$27.22
|
+1.84%($27.72)
|
0.25%
|
2019 Q3
|
≈ 5.75 years
|
|
|
|
GlaxoSmithKline PLC ADR
|
+16.83%
|
+8,414,700
|
58,412,777
|
+0.29%
|
$38.74
|
+33.78%($51.82)
|
1.99%
|
2019 Q3
|
≈ 5.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.